| Novartis Pharma Schweiz AG - Maxidex, Augentropfensuspension |
| 30058 | | 01 | | Maxidex | | Augentropfensuspension | | S01BA01 | | Dexamethasone | | 06.01.1964 | | |
|
| Composition |
| dexamethasonum 1 mg, conserv.: benzalkonii chloridum, excipiens ad suspensionem pro 1 ml. |
| Packungsbestandteile |
| Eye drops | | | | | | | | Active Agent | Dose |
|---|
| Dexamethasone | 1 mg |
| | BAG: Active Agent | Dose |
|---|
| Dexamethasone | 1 mg |
| | | | Inactive agents | | additional_information |
|---|
| Benzalkonium Chloride | | conserv. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | 5 ml | 3.45 | 13.00 | A | SL | Yes |
|
